Kamada Ltd. drugs

3 results
  • varizig

    (Human Varicella-Zoster Immune Globulin)
    Kamada Ltd.
    VARIZIG is indicated for post-exposure prophylaxis of varicella (chickenpox) in high-risk individuals, including immunocompromised patients, newborns, premature infants, and pregnant women without immunity. It reduces varicella severity when given as soon as possible after exposure, ideally within 96 hours.
  • winrho sdf

    (Human Rho(D) Immune Globulin)
    Kamada Ltd.
    WinRho SDF treats immune thrombocytopenic purpura (ITP) in Rho(D)-positive, non-splenectomized patients and suppresses Rh isoimmunization in non-sensitized Rho(D)-negative women during Rh-incompatible pregnancies or obstetric complications, and in individuals transfused with Rho(D)-positive red blood cells.